Hypoxia: Clinical Trials

66 trials for Hypoxia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

66 completed. 66 Phase 2, 26 Phase 1, 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 266Completed 66
Phase 126Completed 26
Phase 36Completed 6

Follow Hypoxia: new trials by email Literature Review of Hypoxia trials Research Report on Hypoxia

Trials (filtered) newest first · largest first

All 66 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
COMBO Endoscopy Oropharyngeal Airway in Sedated Fiberoptic Bronchoscopy for Patients: A Simon Two-Stage Trial
the COMBO Endoscopy Oropharyngeal Airway - Pulmonary Infection, Pulmonary Nodule
Phase 2CompletedZhejiang University1042025-06-232026-02-24
To Observe Haemodynamic Parameters Including, Heart Rate, Blood Pressure, Respiratory Rate , and Oxygen Saturation, With or Without Giving Reversal Agent on Extubation, in Patients Receiving Single Shot of Atracurium , and to Observe Post Operative Residual Paralysis and Airway Reflexes in PACU.
Placebo drug ( normal saline ), neostigmine (reversal agent) - Tachycardia, Hypertension
Phase 1 / Phase 2CompletedZiauddin University1002025-03-122025-07-31
COMBO Endoscopy Oropharyngeal Airway in Sedated Gastrointestinal Endoscopy for Obese Patients
the COMBO Endoscopy Oropharyngeal Airway - Hypoxia, Esophageal Cancer
Phase 2CompletedZhejiang University1072025-02-042025-05-21
Combination COMBO Endoscopy Oropharyngeal Airway With High-Flow Nasal Cannula Oxygenation in Sedated Gastrointestinal Endoscopy for Obese Patients
the COMBO Endoscopy Oropharyngeal Airway with High-Flow Nasal Cannula Oxygenation - Hypoxia, Esophageal Cancer
Phase 2CompletedZhejiang University502025-02-042025-06-25
Oxygen Targets in Acute Heart Failure With Pulmonary Congestion
Oxygen - Acute Heart Failure, Pulmonary Congestion
Phase 2 / Phase 3CompletedCopenhagen University Hospital, Hvidovre1352024-02-012026-10-26
Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial)
Dexmedetomidine Hydrochloride, Morphine Sulfate - Hypoxic-Ischemic Encephalopathy, Pain
Phase 2CompletedUniversity of Utah502022-06-202026-03-06
Multiple N-of-1 Trials of (Intermittent) Hypoxia Therapy in Parkinson's Disease
Hypoxic Gas Mixture - Parkinson Disease, Effect of Drug
Phase 1 / Phase 2CompletedRadboud University Medical Center292022-02-222023-07-21
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
Single Arm, Neonatal Neurobehavioral Scale - Congenital Heart Disease in Children, Hypoxia
Phase 2 / Phase 3CompletedUniversity of Utah1042021-12-172026-07-14
Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced Hypoxemia
Inhaled Low molecular weight heparin, Standard Treatment - COVID-19 Acute Respiratory Distress Syndrome, Hypoxemia
Phase 2 / Phase 3CompletedIstanbul University802021-02-032021-08-05
Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects
Trans Sodium Crocetinate, Normal saline - SARS-CoV-2 (Covid19)
Phase 1 / Phase 2CompletedDiffusion Pharmaceuticals Inc252020-09-102022-04-14
The Effect of Inhaled Nitric Oxide on Maximal Oxygen Consumption During Exercise in Hypoxia
Nitric Oxide, Placebo - Hypoxia
Phase 1 / Phase 2CompletedUniversity of Alberta202020-08-172024-09-19
Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement
Nitric Oxide-Sessions, Nitric Oxide-Continuous and Sessions - Hypoxemia, Pneumonia, Viral
Phase 1 / Phase 2CompletedTomsk National Research Medical Center of the Russian Academy of Sciences202020-07-242026-10-21
Nebulised Dornase Alfa for Treatment of COVID-19 (Coronavirus Disease 2019)
Dornase Alfa Inhalation Solution [Pulmozyme] - COVID-19 (Coronavirus Disease 2019), Hypoxia
Phase 2CompletedUniversity College, London412020-06-162025-01-13
Zilucoplan® in Improving Oxygenation, Short-, Longterm Outcome of COVID19 Patients With Acute Hypoxic Respiratory Failure
Zilucoplan®, Placebo - COVID-19
Phase 2CompletedUniversity Hospital, Ghent812020-05-222023-09-14
Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation
L-ascorbic acid - COVID-19, Hypoxia
Phase 1 / Phase 2CompletedHunter Holmes Mcguire Veteran Affairs Medical Center202020-04-162022-02-25
Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients
Whole-brain radiotherapy - Phase II Clinical Trial, Ninety-six Histologically Confirmed NSCLC Patients With BM
Phase 2CompletedInstituto Nacional de Cancerologia de Mexico962020-03-012020-04-22
A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy
HB-adMSCs - Traumatic Brain Injury
Phase 1 / Phase 2CompletedHope Biosciences LLC242020-01-012026-11-09
Measuring Blood Flow in the Brain After Epileptic Activity
Paracetamol, Nimotop - Epilepsy, Depression
Phase 2CompletedRijnstate Hospital342019-12-052023-11-18
The Effect of Oxygen Therapy on 6MWD in PAH and CTEPH Patients With Hypoxemia
Oxygen - Oxygen Deficiency, Pulmonary Arterial Hypertension
Phase 2CompletedHeidelberg University202019-04-012024-06-20
Effects of Caffeine and Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury
Caffeine, AIH, Placebo - Spinal Cord Injuries
Phase 1 / Phase 2CompletedSpaulding Rehabilitation Hospital362019-01-012023-12-13

Showing 20 of 66. Sign in to see all of them.

Narrower conditions

Hypoxia-Ischemia, Brain (20)  ·  COVID-19 (5)  ·  Hypothermia (5)  ·  Lung Neoplasms (5)  ·  Stroke (4)  ·  Asphyxia (3)  ·  Asphyxia Neonatorum (3)  ·  Brain Injuries, Traumatic (3)  ·  Head and Neck Neoplasms (3)  ·  Hypoxia, Brain (3)  ·  Lymphoma, Follicular (3)  ·  Pneumonia (3)  ·  Seizures (3)  ·  Acute Lung Injury (2)

Broader conditions

Pathological Conditions, Signs and Symptoms (66)  ·  Signs and Symptoms (66)  ·  Signs and Symptoms, Respiratory (66)  ·  Nervous System Diseases (30)  ·  Central Nervous System Diseases (29)  ·  Brain Diseases (28)  ·  Cardiovascular Diseases (26)  ·  Respiratory Tract Diseases (26)  ·  Vascular Diseases (26)  ·  Cerebrovascular Disorders (23)  ·  Brain Ischemia (21)  ·  Lung Diseases (20)  ·  Hypoxia, Brain (19)  ·  Neoplasms (12)

Interventions

Saline Solution (4)  ·  Sodium Chloride (3)  ·  Hypothermia, Induced (2)  ·  Lasers, Gas (2)  ·  Oxygen (2)  ·  3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol (1)  ·  5-hydroxymethylfurfural (1)  ·  Acetaminophen (1)  ·  Albuterol (1)  ·  Amantadine (1)  ·  Aminophylline (1)  ·  Ascorbic Acid (1)  ·  Bumetanide (1)  ·  Caffeine (1)  ·  Celecoxib (1)

Sponsors

University of Utah (3)  ·  Zhejiang University (3)  ·  Colorado State University (2)  ·  Great Ormond Street Hospital for Children NHS Foundation Trust (2)  ·  Radboud University Medical Center (2)  ·  Siemens Molecular Imaging (2)  ·  University Hospitals Bristol and Weston NHS Foundation Trust (2)  ·  University of Alberta (2)  ·  Zhengzhou University (2)  ·  Bayside Health (1)  ·  Centre Henri Becquerel (1)  ·  Chang Gung Memorial Hospital (1)  ·  Copenhagen University Hospital, Hvidovre (1)  ·  Diffusion Pharmaceuticals Inc (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)

Countries

United States (19)  ·  China (7)  ·  United Kingdom (7)  ·  France (4)  ·  Netherlands (4)  ·  Canada (3)  ·  Egypt (3)  ·  Australia (2)  ·  Germany (2)  ·  Israel (2)  ·  Sweden (2)  ·  Uganda (2)  ·  Belgium (1)  ·  Denmark (1)  ·  Greece (1)

Top investigators

Changlian Zhu, MD, PhD (2)  ·  Christopher Bell, PhD (2)  ·  Mariana Baserga, MD (2)  ·  Marianne Thoresen, Professor (2)  ·  Adrian Streinu Cercel, MD (1)  ·  Alan C Perkins, PhD (1)  ·  Alan Waxman, MD (1)  ·  Ashley Bjorklund, MD (1)  ·  Asma Abdus Salam, Consultant anaesthesiology (1)  ·  Ayca Yildiz-Pekoz, PhD (1)  ·  Bart N Lambrecht, MDPhD (1)  ·  Brian C Davis, MD (1)  ·  Charles S Cox, MD (1)  ·  Christina I. Olofsson, MD, PhD (1)

Results publications

PMID 24524452, PMID 10492412, PMID 10793602, PMID 12717123, PMID 1356374, PMID 15607598, PMID 15607599, PMID 15683820, PMID 17122578, PMID 17893459, PMID 18708248, PMID 19834012, PMID 19854090, PMID 20385632, PMID 20576632, PMID 21195036, PMID 21852153, PMID 22091288, PMID 22805873, PMID 22950861, PMID 23372884, PMID 23682548, PMID 23897243, PMID 24815497, PMID 25512461, PMID 25765333, PMID 25794112, PMID 26156116, PMID 26680684, PMID 28329240, PMID 28606907, PMID 29028696, PMID 29261883, PMID 29800014, PMID 29866165, PMID 30207593, PMID 30573962, PMID 30661082, PMID 30679288, PMID 31155392, PMID 31261373, PMID 32399752, PMID 33213529, PMID 33415555, PMID 34667360, PMID 35157994, PMID 35436940, PMID 35836147, PMID 35841234, PMID 35945604

NIH funding

2014 (1), 2017 (1), 2018 (1), R01HD038600 (1), R01HD081274 (1), R01NS038062 (1), R01NS061860 (1), U24HL135691 (1)